Dopaminergic Dysfunction: A Key Player in Parkinson’s Disease Motivational Symptoms This study reveals a significant link between dopaminergic dysfunction and the emergence of motivational symptoms in Parkinson’s disease. Striatal DAT imaging emerges as a potential tool for predicting apathy/anhedonia risk, opening new avenues for intervention strategies.

Unpacking the Financial Implications of Medical Malpractice Understanding the financial environment of medical malpractice is essential for physicians. How might the costs associated with medical malpractice cases affect your business? Discover significant takeaways and risk-management techniques from a recent, high-profile case.

Decoding the Interplay of Fasting, mTOR, and Seizure Control This article illuminates the critical function of fasting and mTOR regulation in the treatment of epilepsy by delving into the intricate molecular processes.

Evaluating the Timing of DOAC Initiation Post-Stroke: Key Findings Here are the key findings from a recent multi-country, open-label research that explores the best time to start direct oral anticoagulants (DOACs) in atrial fibrillation patients after a stroke.

Decoding the Efficacy: Ketamine and ECT in the Battle Against Treatment-Resistant Depression As you delve into the comparative effectiveness of ketamine and ECT, NEJM highlights the key findings from a recent noninferiority trial that could reshape your understanding of these treatments.

The SSRI inhibitor was previously limited to adults. As physicians, we are continually seeking effective treatment options for our pediatric patients. The recent FDA approval of Lexapro for pediatric GAD treatment marks a significant advancement in this field.